NEIRG Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

NEIRG Wealth Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-3,733	Closed	-$474K	–	48
2023 Q2	$474K	Hold	3,733	–	–	0.09%	100
2023 Q1	$482K	Hold	3,733	–	–	0.08%	105
2022 Q4	$490K	Buy	3,733 +1	+0%	+$129	0.09%	106
2022 Q3	$437K	Sell	3,732 -1,200	-24%	-$149K	0.09%	106
2022 Q2	$580K	Buy	4,932 +100	+2%	+$11.9K	0.13%	98
2022 Q1	$630K	Buy	4,832 +1,101	+30%	+$143K	0.12%	93
2021 Q4	$569K	Buy	+3,731	New	+$578K	0.11%	80

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

NEIRG Wealth Management's IBB Position: Q3 2023 in Review

NEIRG Wealth Management sold out of iShares Biotechnology ETF (IBB) in Q3 2023, closing a stake of 3,733 shares — an estimated $474K sold.

NEIRG Wealth Management first reported a position in IBB in Q4 2021 and held it in 7 quarters. The position peaked at $630K in Q1 2022. 833 funds tracked by Wall St. Rank hold IBB as of Q3 2023.

NEIRG Wealth Management reported no remaining iShares Biotechnology ETF position as of Q3 2023 after selling out during the quarter.
NEIRG Wealth Management sold 3,733 iShares Biotechnology ETF shares in Q3 2023, an estimated $474K.
NEIRG Wealth Management first reported a position in iShares Biotechnology ETF in Q4 2021 and held it in 7 quarters.
NEIRG Wealth Management's iShares Biotechnology ETF position peaked at $630K in Q1 2022.
833 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2023.

Based on NEIRG Wealth Management's 13F filing for Q3 2023.